Evidence map›Paper›PMID 27537422›Full record

ReviewCritical reviews in toxicology2017

Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Eileen D Kuempel, Marie-Claude Jaurand, Peter Møller, Yasuo Morimoto, Norihiro Kobayashi, Kent E Pinkerton, Linda M Sargent, Roel C H Vermeulen, Bice Fubini, Agnes B Kane

Open access · greenAbstract readReview
In one paragraph

Review in Critical reviews in toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Novel pyrrolo[2,1-RSC advances · 2025
    Article
  5. Article
  6. Article
  7. Update on Occupational Cancer for Better Cancer Prevention and Control.Asian Pacific journal of cancer prevention : APJCP · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Current causes of mesothelioma: how has the asbestos ban changed the perspective?Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 6 countries.

Eileen D Kuempela National Institute for Occupational Safety and Health , Cincinnati , OH , USA.
Marie-Claude Jaurandb Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche , UMR 1162 , Paris , France.
Peter Møllerf Department of Public Health , University of Copenhagen , Copenhagen , Denmark.
Yasuo Morimotog Department of Occupational Pneumology , University of Occupational and Environmental Health , Kitakyushu City , Japan.
Norihiro Kobayashih National Institute of Health Sciences , Tokyo , Japan.
Kent E Pinkertoni Center for Health and the Environment, University of California , Davis , California , USA.
Linda M Sargentj National Institute for Occupational Safety and Health , Morgantown , West Virginia , USA.
Roel C H Vermeulenk Institute for Risk Assessment Sciences, Utrecht University , Utrecht , The Netherlands.
Bice Fubinil Department of Chemistry and "G.Scansetti" Interdepartmental Center , Università degli Studi di Torino , Torino , Italy.
Agnes B Kanem Department of Pathology and Laboratory Medicine , Brown University , Providence , RI , USA.
National Institute for Occupational Safety and Health · USBrown University · USInserm · FRNational Institute of Health Sciences · JPUniversity of California, Davis · USUniversity of Copenhagen · DKUniversity of Occupational and Environmental Health Japan · JPUniversity of Turin · ITUtrecht University · NL

Funding

Vapor Pressures and Thermodynamic Properties of Complex Organic MixturesP42ES013660 · NIEHS · BROWN UNIVERSITY · PI BOEKELHEIDE, KIM, HURT, ROBERT H. · 2005 to 2020
$37.7M
Intramural CDC HHS CC999999NIEHS NIH HHS P42 ES013660
6 · The paper itself

Abstract

In an evaluation of carbon nanotubes (CNTs) for the IARC Monograph 111, the Mechanisms Subgroup was tasked with assessing the strength of evidence on the potential carcinogenicity of CNTs in humans. The mechanistic evidence was considered to be not strong enough to alter the evaluations based on the animal data. In this paper, we provide an extended, in-depth examination of the in vivo and in vitro experimental studies according to current hypotheses on the carcinogenicity of inhaled particles and fibers. We cite additional studies of CNTs that were not available at the time of the IARC meeting in October 2014, and extend our evaluation to include carbon nanofibers (CNFs). Finally, we identify key data gaps and suggest research needs to reduce uncertainty. The focus of this review is on the cancer risk to workers exposed to airborne CNT or CNF during the production and use of these materials. The findings of this review, in general, affirm those of the original evaluation on the inadequate or limited evidence of carcinogenicity for most types of CNTs and CNFs at this time, and possible carcinogenicity of one type of CNT (MWCNT-7). The key evidence gaps to be filled by research include: investigation of possible associations between in vitro and early-stage in vivo events that may be predictive of lung cancer or mesothelioma, and systematic analysis of dose-response relationships across materials, including evaluation of the influence of physico-chemical properties and experimental factors on the observation of nonmalignant and malignant endpoints.

Indexed as

Carcinogenicity TestsAnimalsHumansNanofibersNanotubes, CarbonNanotubes, CarbonCancer mechanismscarbon nanofiberscarbon nanotubescell proliferationfibrosisgenotoxicityinflammationlung cancermesotheliomaparticle retentionpulmonarytranslocation

Identifiers

PMID27537422
PMCPMC5555643
OpenAlexW2517028335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.